Presentations

Immune Checkpoint Inhibitor-Based Downstaging Therapy for HCC Beyond the Milan Criteria: A Multicentre, Retrospective, Matched Cohort Study on Post-Liver Transplant Outcomes

Meiching Ong (CN)

Bio Abstract

A Retinoid Metabolism–MIF Axis Drives Immune Evasion of Circulating Tumor Cells in Hepatocellular Carcinoma

Ruilin Cai (CN)

Bio Abstract

The impact of the gut-liver axis on intrahepatic NK cell activity: Identifying modulators of efficacy in donor-derived NK cell therapy for HCC recurrence after liver transplantation

Masahiro Ohira (JP)

Bio Abstract

A Donor Risk Factor Inclusive Advanced Machine Learning Equation For Predicting Cholangiocarcinoma Recurrence After Liver Transplantation

Andrea Schlegel (US)

Bio Abstract

Temporal trends in the etiologies of hepatocellular carcinoma and non-hepatocellular carcinoma associated liver transplants in the US in the last decade

Behnam Saberi (US)

Bio Abstract

Stereotactic body radiotherapy as neoadjuvant treatment in liver transplantation for klatskin tumor

Aliaksei Shcherba (BY)

Bio Abstract